Maoliang Li

Title: The Innovations of Maoliang Li

Introduction

Maoliang Li is a notable inventor based in Chengdu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of diphosphonate compounds. His work has implications for the treatment of bone-related conditions.

Latest Patents

Maoliang Li holds a patent for a diphosphonate compound and a method for preparing the same, along with its application. This new diphosphonate compound exhibits an activity in inhibiting osteoclasts equivalent to alendronate sodium. Additionally, it shows a higher activity in affecting the proliferation of osteoblasts compared to positive control compounds, which exhibit a weaker effect on osteoblast proliferation. The patent provides an administration schedule for the diphosphonate compound, showcasing its potential therapeutic benefits.

Career Highlights

Throughout his career, Maoliang Li has worked with various pharmaceutical companies, including Chengdu Yunke Pharmaceutical Co., Ltd. and Chengdu New Radiomedicine Technology Co., Ltd. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Maoliang Li has collaborated with notable colleagues such as Mingqi Li and Han Wang. These partnerships have contributed to his research and development efforts in the pharmaceutical industry.

Conclusion

Maoliang Li's contributions to the field of pharmaceuticals, particularly through his innovative diphosphonate compound, highlight his role as a significant inventor. His work continues to influence the development of treatments for bone-related conditions.